The utility and effectiveness of screening mammography in diagnosing breast cancer at earlier stages and reducing disease-specific mortality remain controversial especially as to when to start and stop routine mammographic screening, and whether mammograms should be performed annually or biennially in average-risk women. This manuscript will analyze the available moderate and high-quality data to analyze both the benefits (lives saved and life-years saved) and inconveniences/harms (additional views, extra biopsies/overdiagnosis, and overtreatment of ductal carcinoma in situ) of different mammography screening guidelines to assist the practitioner in counseling their patients in clinical practice.
Using autopsy series to estimate the disease "reservoir" for ductal carcinoma in situ of the breast: how much more breast cancer can we find?
Breast screening: the psychological sequelae of false-positive recall in women with and without a family history of breast cancer
False positive results do not have a negative effect on reattendance for subsequent breast screening
High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group
Invasive cancers detected after breast cancer screening yielded a negative result: relationship of mammographic density to tumor prognostic factors
Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer
Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study
Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms
Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England
USPSTF erroneously understated life-years-gained benefit of mammographic screening of women in their 40s
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk
Stage-specific breast cancer incidence rates among participants and non-participants of a population-based mammographic screening program
The effect of false positive breast screening examinations on subsequent attendance: retrospective cohort study
Reduction in late-stage breast cancer incidence in the mammography era: Implications for overdiagnosis of invasive cancer
Implications of CISNET modeling on number needed to screen and mortality reduction with digital mammography in women 40-49 years old
Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society
Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study
Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.